Nath Bio-Genes (India) Limited
Incorporated in 1993, Nath Bio-Genes Ltdis in the business of Production, Processing,and Marketing of Hybrid and GM Seeds
What Nath files
- Others30
- Important11
- Board Meeting7
- Updates6
- Investor Meet3
- Dividend/Bonus2
Nath Bio-Genes delivered strong Q1FY27 results: Revenue grew 15% to ₹322.8 Cr, EBITDA rose 17% to ₹35.1 Cr, and PAT increased 12% to ₹32.7 Cr. Operational highlights include Maize volume up 44% (value 59%) and Paddy volume up 19% (value 34%).
Company reported strong full-year revenue growth of 19% to ₹431.6 Cr, driven by robust cotton, paddy, and surging maize sales (+78%). Uzbekistan JV added ₹15 Cr. Increased inventory prepares for future demand, with management confident of sustained growth despite climate shifts.
Nath Bio-Genes shared the audio recording of its conference call discussing the financial results for the quarter and year ended March 31. The recording is available on the company website for investor review.
Nath Bio-Genes FY26 revenue grew 19% to ₹431.6 Cr, fueled by strong Cotton, Paddy, and Maize sales. PBT rose 11% to ₹49.1 Cr, though PAT dipped 8% and margins compressed. A new ₹15 Cr international topline from Uzbekistan marks significant expansion.
Nath Bio-Genes will host an Earning Conference Call to discuss Q4 & FY26 financial results. Key management, including the MD & CFO, will participate. Investors can pre-register to join.